The COPD Foundation on Its Twentieth Anniversary

Overview

Journal Chronic Obstr Pulm Dis

Date 2024 May 29

PMID 38809791

Authors

Elisha Malanga

Byron Thomashow

Jean Wright

Linda Walsh

Cathy Gray Carlomagno

Jamie Sullivan

Stephanie Williams

Bruce E Miller

Crystal Rothhaar

William Clark

Alan Hamilton

Michael Hess

Delia Prieto Oliver

Vincent Malanga

Peter Amari

James Crapo

David M Mannino

Affiliations

Soon will be listed here.

Citing Articles

Are We Getting Closer to the "Cholesterol" for Chronic Respiratory Disease?.

Mannino D, Wright J Am J Respir Crit Care Med. 2024; .

PMID: 39265184 PMC: 11755355. DOI: 10.1164/rccm.202407-1480ED.

References

Pauwels R, Buist A, Calverley P, Jenkins C, Hurd S . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001; 163(5):1256-76. DOI: 10.1164/ajrccm.163.5.2101039. View

Agusti A, Ambrosino N, Blackstock F, Bourbeau J, Casaburi R, Celli B . COPD: Providing the right treatment for the right patient at the right time. Respir Med. 2023; 207:107041. DOI: 10.1016/j.rmed.2022.107041. View

Aksamit T, ODonnell A, Barker A, Olivier K, Winthrop K, Daniels M . Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research Registry. Chest. 2016; 151(5):982-992. PMC: 6026266. DOI: 10.1016/j.chest.2016.10.055. View

Henkle E, Aksamit T, Barker A, Curtis J, Daley C, Daniels M . Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry. Chest. 2017; 152(6):1120-1127. PMC: 6026272. DOI: 10.1016/j.chest.2017.04.167. View

Crapo J, Barnes P, Jones P, Make B, Mannino D . The Launch of a New COPD Journal. Chronic Obstr Pulm Dis. 2017; 1(1):1-3. PMC: 5559135. DOI: 10.15326/jcopdf.1.1.2014.0128. View

Yawn B, Make B, Mannino D, Lopez C, Murray S, Thomashow B . Impact of the COVID-19 Pandemic on Outcomes of CAPTURE: A Primary Care Chronic Obstructive Pulmonary Disease Screening Clinical Trial. Ann Am Thorac Soc. 2023; 21(1):176-179. PMC: 10867910. DOI: 10.1513/AnnalsATS.202305-478RL. View

Biney I, Ari A, Barjaktarevic I, Carlin B, Christiani D, Cochran L . Guidance on Mitigating the Risk of Transmitting Respiratory Infections During Nebulization by the COPD Foundation Nebulizer Consortium. Chest. 2023; 165(3):653-668. DOI: 10.1016/j.chest.2023.11.013. View

Miller B, Tal-Singer R, Rennard S, Furtwaengler A, Leidy N, Lowings M . Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium. Am J Respir Crit Care Med. 2016; 193(6):607-13. DOI: 10.1164/rccm.201509-1722PP. View

Pleasants R, Heidari K, Ohar J, Donohue J, Lugogo N, Richard C . Use of a Cross-Sectional Survey in the Adult Population to Characterize Persons at High-Risk for Chronic Obstructive Pulmonary Disease. Healthcare (Basel). 2019; 7(1). PMC: 6473439. DOI: 10.3390/healthcare7010012. View

10.

Hurst J, Elborn J, Soyza A . COPD-bronchiectasis overlap syndrome. Eur Respir J. 2015; 45(2):310-3. DOI: 10.1183/09031936.00170014. View

11.

Couper D, LaVange L, Han M, Barr R, Bleecker E, Hoffman E . Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Thorax. 2013; 69(5):491-4. PMC: 3954445. DOI: 10.1136/thoraxjnl-2013-203897. View

12.

Martinez F, Mannino D, Leidy N, Malley K, Bacci E, Barr R . A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2016; 195(6):748-756. PMC: 5363964. DOI: 10.1164/rccm.201603-0622OC. View

13.

Martinez F, Han M, Lopez C, Murray S, Mannino D, Anderson S . Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings. JAMA. 2023; 329(6):490-501. PMC: 9929696. DOI: 10.1001/jama.2023.0128. View

14.

Casaburi R, Celli B, Crapo J, Criner G, Croxton T, Gaw A . The COPD Biomarker Qualification Consortium (CBQC). COPD. 2013; 10(3):367-77. DOI: 10.3109/15412555.2012.752807. View

15.

Despotes K, Choate R, Addrizzo-Harris D, Aksamit T, Barker A, Basavaraj A . Nutrition and Markers of Disease Severity in Patients With Bronchiectasis. Chronic Obstr Pulm Dis. 2020; 7(4):390-403. PMC: 7883909. DOI: 10.15326/jcopdf.7.4.2020.0178. View

16.

Gruss I, McCreary G, Ivlev I, Houlihan M, Yawn B, Pasquale C . Developing a patient-driven chronic obstructive pulmonary disease (COPD) research agenda in the U.S. J Patient Rep Outcomes. 2021; 5(1):126. PMC: 8643383. DOI: 10.1186/s41687-021-00399-7. View

17.

Dou S, Zheng C, Cui L, Xie M, Wang W, Tian H . High prevalence of bronchiectasis in emphysema-predominant COPD patients. Int J Chron Obstruct Pulmon Dis. 2018; 13:2041-2047. PMC: 6029612. DOI: 10.2147/COPD.S163243. View

18.

Casaburi R, Hess M, Porszasz J, Clark W, Diesem R, Tal-Singer R . Evaluation of Over-the-Counter Portable Oxygen Concentrators Utilizing a Metabolic Simulator. Respir Care. 2022; 68(4):445-451. PMC: 10173114. DOI: 10.4187/respcare.10495. View

19.

Lowe K, Regan E, Anzueto A, Austin E, Austin J, Beaty T . COPDGene 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease. Chronic Obstr Pulm Dis. 2019; 6(5):384-399. PMC: 7020846. DOI: 10.15326/jcopdf.6.5.2019.0149. View

20.

Price D, Miravitlles M, Pavord I, Thomas M, Wedzicha J, Haughney J . First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis. NPJ Prim Care Respir Med. 2016; 26:16061. PMC: 5093405. DOI: 10.1038/npjpcrm.2016.61. View